Reactivité: Hepatitis C Virus (HCV)
Hôte: Escherichia coli (E. coli)
ELISA, WB
N° du produit ABIN5676021
Aperçu rapide pour Nucleocapsid (Core) (AA 2-192) Peptide (ABIN5676021)
Antigène
Nucleocapsid (Core)
Origine
Hepatitis C Virus (HCV)
Source
Escherichia coli (E. coli)
Application
ELISA, Western Blotting (WB)
Type de proteíne
Recombinant
Protein Region
AA 2-192
Attributs du produit
Hepatitis C Virus Core 22 kDa recombinant protein Expression System: E.coli
Purification
Proprietary chromatographic technique
Pureté
> 95 % pure
Indications d'application
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Liquid
Buffer
25 mM tris-HCl, pH-8, with 1.5 M urea, 0.2 % Triton-X and 52 % glycerol.
Conseil sur la manipulation
Avoid repeated freeze/thaw cycles.
Stock
RT/-20 °C
Antigène
Nucleocapsid (Core)
Classe de substances
Viral Protein
Sujet
HCV is a small 50nm, enveloped, single-stranded, positive sense RNAvirus in the family Flaviviridae. HCV has a high rate of replication with approximately one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes(1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6). Alternative Names: HCV Recombinant protein, Hepatitis C protein, Hep C protein, HCV protein, HVC Nucleocapsid (Core) 22 kDa protein